Bharat Immunological & Biological Corporation Ltd EPS
Bharat Immunological & Biological Corporation Ltd
NSE: BHARATIMMUNOLOG
EPS
Key Highlights
- The Earning per Share of Bharat Immunological & Biological Corporation Ltd is ₹ -4.18 as of 06 Feb 26 .
Historical P/B Ratio of Bharat Immunological & Biological Corporation Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Bharat Immunological & Biological Corporation Ltd
Company Fundamentals for Bharat Immunological & Biological Corporation Ltd
Market Cap
87 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
0.0
Day’s High
21.15
Day’s Low
19.56
DTE
0.9
ROE
-23.0
52 Week High
28.8
52 Week Low
16.55
ROCE
-11.2
Market Price of Bharat Immunological & Biological Corporation Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Feb 2026 | 20.15 |
| 05 Feb 2026 | 20.44 |
| 04 Feb 2026 | 20.65 |
| 03 Feb 2026 | 19.49 |
| 02 Feb 2026 | 19.19 |
| 01 Feb 2026 | 18.55 |
| 30 Jan 2026 | 17.95 |
| 29 Jan 2026 | 17.76 |
| 28 Jan 2026 | 17.51 |
| 27 Jan 2026 | 17.2 |
SWOT Analysis Of Bharat Immunological & Biological Corporation Ltd
BlinkX Score for Bharat Immunological & Biological Corporation Ltd
Asset Value vs Market Value of Bharat Immunological & Biological Corporation Ltd
Market Value
₹ 87
Asset Value
Value addition
0.5 X
₹ 60
* All values are in ₹ crores
Competitive Comparison of EPS
| Company | Market Cap | EPS |
|---|
Bharat Immunological & Biological Corporation Ltd | 87.01 | - |
Sun Pharmaceutical Industries Ltd | 406615 | 50.61 |
Divis Laboratories Ltd | 159943 | 93.61 |
Torrent Pharmaceuticals Ltd | 133336 | 64.01 |
Cipla Ltd | 107499 | 58.86 |
Dr Reddys Laboratories Ltd | 103590 | 66.72 |
| Company | |
|---|---|
| Bharat Immunological & Biological Corporation Ltd | 87.01 |
| Sun Pharmaceutical Industries Ltd | 406615 |
| Divis Laboratories Ltd | 159943 |
| Torrent Pharmaceuticals Ltd | 133336 |
| Cipla Ltd | 107499 |
| Dr Reddys Laboratories Ltd | 103590 |
Historical Market Cap of Bharat Immunological & Biological Corporation Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Bharat Immunological & Biological Corporation Ltd
Historical Revenue of Bharat Immunological & Biological Corporation Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Bharat Immunological & Biological Corporation Ltd
Historical EBITDA of Bharat Immunological & Biological Corporation Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Bharat Immunological & Biological Corporation Ltd
Historical Net Profit of Bharat Immunological & Biological Corporation Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Bharat Immunological & Biological Corporation Ltd
Dividend Payout Over Time
Bharat Immunological & Biological Corporation Ltd News Hub
Bharat Immunological & Biolog.Corp. to hold board meeting
Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the Company on
Read more
10 Aug 24
Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group
Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartronics India
Read more
06 Jan 25
Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group
Relicab Cable Manufacturing Ltd, Precision Wires India Ltd, Brainbees Solutions Ltd and Flair Writin
Read more
08 Jan 25
